Pronóstico del mercado de inmunohistoquímica de Asia Pacífico hasta 2028: impacto de COVID-19 y análisis regional por aplicación (diagnóstico y pruebas de fármacos), producto (anticuerpos, equipos, reactivos y kits) y usuario final (hospitales y laboratorios de diagnóstico, institutos de investigación y otros) )

Introducción al mercado

APAC es el mercado regional de inmunohistoquímica de más rápido crecimiento; y China, India, Japón, Corea del Sur, Australia y el resto de APAC son los principales contribuyentes al mercado en esta región. China lideró el mercado en 2021. El crecimiento del mercado se atribuye al aumento de las actividades de I+D, al aumento de las inversiones en el sector sanitario en los países en desarrollo y al aumento de las colaboraciones entre la subcontratación regulatoria y los desarrolladores de medicamentos. Los actores del mercado están lanzando productos. Por ejemplo, en agosto de 2020, Gilead Sciences Inc. recibió la aprobación de Truvada, un medicamento de prevención del VIH para su uso en medicina para adultos y adolescentes en China. Esta aprobación ayudará a prevenir el VIH entre la población sana. Numerosas enfermedades infecciosas están surgiendo, reemergiendo o provocando brotes recurrentes en la región de Asia y el Pacífico. Las personas que viajan con mayor frecuencia, viven en áreas más densamente pobladas y entran en contacto más cercano con animales salvajes han aumentado el potencial de que las enfermedades infecciosas emergentes se propaguen rápidamente. La actual situación de la COVID-19 también ha incrementado la vigilancia del virus de la gripe entre la población para mejorar el diagnóstico de la enfermedad. Según la Comisión Nacional de Salud (NHC) de China, hasta el 26 de marzo de 2020 se habían notificado en China un total de 81.285 casos de infección por coronavirus, con un número total de 3.287 muertes debido al brote del virus. La enfermedad se transmitió a un ritmo rápido en las fases iniciales. Sin embargo, también se espera que la prevalencia de enfermedades debidas a diferentes infecciones virales, como el rotavirus viral, el virus de la hepatitis AE, el virus del dengue y otras, impulsen el mercado en el período de previsión. Se espera que esto, el aumento de las enfermedades infecciosas emergentes, la mejora de las capacidades de diagnóstico y el aumento de los programas gubernamentales relacionados con una mejor comprensión de las enfermedades virales impulsen el crecimiento del mercado de inmunohistoquímica en los próximos años.

Los países de APAC, especialmente India, están muy afectados debido al brote de COVID-19. Las perturbaciones en la cadena de suministro y la enorme demanda de tratamientos eficientes para la terapia de COVID-19 han puesto a la industria de investigación sanitaria en una situación crucial en APAC. Se han tomado medidas prohibitivas para controlar la propagación del nuevo coronavirus. La pandemia de COVID-19 ha afectado negativamente a las economías de la región. La situación socioeconómica se vio gravemente afectada, con un aumento de la inflación negativa, el PIB y un aumento del desempleo regional. Países como China, Japón, Singapur y Corea del Sur están viendo un mayor interés en los ensayos clínicos. Los altos costos en los países occidentales también están contribuyendo al flujo de subcontratación de asuntos médicos hacia APAC. Para ampliar las ventas al mercado asiático, las empresas farmacéuticas están tomando conciencia de los entornos regulatorios nuevos y cambiantes para medicamentos, dispositivos y diagnósticos in vitro. En Asia se implementan con frecuencia regulaciones nuevas o mejoradas, incluidos cambios en las normas GMP, controles de precios de medicamentos y sistemas regulatorios de dispositivos médicos. Se requiere orientación y asesoramiento de terceros como parte de cualquier adquisición o mejora de los estándares actuales. Cada vez más, los proveedores de servicios de subcontratación externos desempeñan un papel importante en el apoyo al mercado asociado en APAC. Sin embargo, el mercado se ha estabilizado en comparación con las fases iniciales de la pandemia debido a los procedimientos de control, la concienciación entre la gente, la disponibilidad de vacunas y las políticas gubernamentales de apoyo de la empresa en el mercado relacionado.

< u>Descripción general y dinámica del mercado

Se espera que el mercado de inmunohistoquímica de APAC crezca de 483,76 millones de dólares en 2021 a 818,00 millones de dólares en 2028; se estima que crecerá a una tasa compuesta anual del 7,8% de 2021 a 2028. La inmunohistoquímica (IHC) se refiere a una aplicación importante de anticuerpos monoclonales y policlonales para la determinación tisular y la distribución de antígenos de una enfermedad particular. Se utiliza principalmente para detectar varios trastornos infecciosos como el dengue, la hepatitis y el virus de la inmunodeficiencia humana (VIH). Las afecciones médicas crónicas como la obesidad, el cáncer, la diabetes, las enfermedades cardíacas y los accidentes cerebrovasculares también se consideran las principales aplicaciones de la inmunohistoquímica que ayudan en el diagnóstico de estas enfermedades. La diabetes prevalece a un ritmo elevado entre la población geriátrica de toda la región. La prevalencia de diabetes es mayor en personas con sobrepeso y obesidad. Las tasas de obesidad han aumentado rápidamente en las economías desarrolladas y en desarrollo de toda la región. Factores como el estilo de vida poco saludable y el sedentarismo se encuentran entre los principales responsables del aumento del número de personas obesas. Las enfermedades cardiovasculares (ECV) incluyen enfermedades cerebrovasculares, enfermedades cardíacas reumáticas, enfermedades coronarias y otras afecciones. Es la causa más importante de morbilidad y mortalidad en toda la región. Además, ha habido un aumento en las tasas de incidencia y mortalidad del cáncer en toda la región, lo que convierte al cáncer en la principal causa de muerte. Se espera que tal aumento en la incidencia de enfermedades crónicas e infecciosas cree una demanda de pruebas de inmunoensayo en la región APAC.

Segmentos de mercado clave

En términos de producto, el segmento de anticuerpos representó la mayor participación del mercado de inmunohistoquímica de APAC en 2020. En términos de aplicación, el segmento de diagnóstico tuvo una mayor participación de mercado del mercado de inmunohistoquímica de APAC en 2020. Además, el segmento de hospitales y laboratorios de diagnóstico tuvo una mayor participación en el mercado de inmunohistoquímica de APAC según el usuario final en 2020.

Principales fuentes y empresas incluidas

Algunas de las principales fuentes primarias y secundarias a las que se hace referencia para preparar este informe sobre el mercado de inmunohistoquímica de APAC son los sitios web de las empresas, los informes anuales, los informes financieros, los documentos del gobierno nacional y las bases de datos estadísticas, entre otros. Las principales empresas que figuran en el informe son Abcam plc; Tecnologías Agilent, Inc.; Bio SB; LABORATORIOS BIO-RAD INC.; Tecnología de señalización celular, Inc.; Danaher; F. HOFFMANN-LA ROCHE LTD.; MERCK KGaA; PerkinElmer Inc.; y THERMO FISHER SCIENTIFIC INC.

Informe de razones para comprar

Comprender el panorama del mercado de inmunohistoquímica de APAC e identificar los segmentos de mercado que tienen más probabilidades de garantizar un fuerte retorno
Manténgase a la vanguardia al comprender los cambios constantes panorama competitivo para el mercado de inmunohistoquímica de APAC
Planifique de manera eficiente fusiones y adquisiciones y acuerdos de asociación en el mercado de inmunohistoquímica de APAC identificando segmentos de mercado con las ventas probables más prometedoras
Ayuda a tomar decisiones comerciales informadas desde una perspectiva perspicaz y análisis completo del desempeño del mercado de varios segmentos del mercado de inmunohistoquímica de APAC
Obtenga un pronóstico de ingresos de mercado para varios segmentos de 2021 a 2028 en la región de APAC.

Segmentación del mercado de inmunohistoquímica APAC

Mercado de inmunohistoquímica de APAC: por producto

Equipo
- Sistemas de tinción de portaobjetos
- Sistemas de microarrays de tejidos
- Sistemas de procesamiento de tejidos
- Escáneres de portaobjetos
- Otros equipos
Anticuerpos
- Anticuerpos primarios
- Anticuerpos secundarios
Reactivos
- Tinciones histológicas
- Reactivos de bloqueo y fijación
- Sustratos cromogénicos
- Reactivos de fijación
- Estabilizadores
- Disolventes orgánicos
- Enzimas proteolíticas
- Diluyentes
Kits

Mercado de inmunohistoquímica de APAC - Por aplicación

Diagnóstico
- Cáncer
- Enfermedades infecciosas
- Enfermedades autoinmunes
- Diabetes Mellitus
- Enfermedades Nefrológicas
- Otras
Pruebas de Medicamentos

Mercado de inmunohistoquímica de APAC: Por usuario final

Hospitales y laboratorios de diagnóstico
Institutos de investigación
Otros

Mercado de inmunohistoquímica de APAC: por país

China
Japón
India
Australia
Corea del Sur
Resto del mercado de Inmunohistoquímica de APAC

APAC: perfiles de empresas

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 APAC Immunohistochemistry Market – By Product

1.3.2 APAC Immunohistochemistry Market – By Application

1.3.3 APAC Immunohistochemistry Market – By End User

1.3.4 APAC Immunohistochemistry Market – By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. APAC Immunohistochemistry Market – Market Landscape

4.1 Overview

4.2 APAC PEST Analysis

4.3 Experts Opinion

5. APAC Immunohistochemistry Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Escalating Incidences of Chronic and Infectious Diseases

5.1.2 Surging R&D Investments by Biotechnology & Biopharmaceutical Companies

5.2 Key Market Restraints

5.2.1 Complications Related to Immunohistochemistry

5.3 Key Market Opportunities

5.3.1 Burgeoning Opportunities in Emerging Countries

5.4 Future Trends

5.4.1 Growing Acceptance of Automation in Immunohistochemistry

5.5 Impact Analysis

6. Immunohistochemistry Market – APAC Analysis

6.1 APAC Immunohistochemistry Market Revenue Forecast and Analysis

7. APAC Immunohistochemistry Market Analysis– By Product

7.1 Overview

7.2 APAC Immunohistochemistry Market, By Product 2021 & 2028 (%)

7.3 Antibodies

7.3.1 Overview

7.3.2 Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.3.3 Primary Antibodies

7.3.3.1 Overview

7.3.3.2 Primary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.3.4 Secondary Antibodies

7.3.4.1 Overview

7.3.4.2 Secondary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4 Equipment Market

7.4.1 Overview

7.4.2 Equipment: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.3 Slide Staining Systems

7.4.3.1 Overview

7.4.3.2 Slide Staining Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.4 Tissue Microarrays

7.4.4.1 Overview

7.4.4.2 Tissue Microarrays: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.5 Tissue Processing Systems

7.4.5.1 Overview

7.4.5.2 Tissue Processing Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.6 Slide Scanners

7.4.6.1 Overview

7.4.6.2 Slide Scanners: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.7 Other Equipments

7.4.7.1 Overview

7.4.7.2 Other Equipments: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5 Reagents Market

7.5.1 Overview

7.5.2 Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.3 Histological Stains

7.5.3.1 Overview

7.5.3.2 Histological Stains: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.4 Blocking Sera & Reagents Market

7.5.4.1 Overview

7.5.4.2 Blocking Sera & Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.5 Chromogenic Substrates Market

7.5.5.1 Overview

7.5.5.2 Chromogenic Substrates: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.6 Stabilizers

7.5.6.1 Overview

7.5.6.2 Stabilizers Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.7 Proteolytic Enzymes

7.5.7.1 Overview

7.5.7.2 Proteolytic Enzymes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.8 Organic Solvents

7.5.8.1 Overview

7.5.8.2 Organic Solvents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.9 Fixation Reagents

7.5.9.1 Overview

7.5.9.2 Fixation Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.10 Diluents

7.5.10.1 Overview

7.5.10.2 Diluents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.6 Kits Market

7.6.1 Overview

7.6.2 Kits: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

8. APAC Immunohistochemistry Market Analysis – By Application

8.1 Overview

8.2 APAC Immunohistochemistry Market Share by Application 2021 & 2028 (%)

8.3 Diagnostics

8.3.1 Overview

8.3.2 Diagnostics Market Revenue and Forecast to 2028 (US$ Mn)

8.3.3 Cancer

8.3.3.1 Overview

8.3.3.2 Cancer Market Revenue and Forecast to 2028 (US$ Mn)

8.3.4 Infectious Diseases

8.3.4.1 Overview

8.3.4.2 Infectious Diseases Market Revenue and Forecast to 2028 (US$ Mn)

8.3.5 Autoimmune Diseases

8.3.5.1 Overview

8.3.5.2 Autoimmune Diseases Market Revenue and Forecast to 2028 (US$ Mn)

8.3.6 Diabetes Mellitus

8.3.6.1 Overview

8.3.6.2 Diabetes Mellitus Market Revenue and Forecast to 2028 (US$ Mn)

8.3.7 Nephrological Diseases

8.3.7.1 Overview

8.3.7.2 Nephrological Diseases Market Revenue and Forecast to 2028 (US$ Mn)

8.3.8 Others

8.3.8.1 Overview

8.3.8.2 Others Market Revenue and Forecast to 2028 (US$ Mn)

8.4 Drug Testing

8.4.1 Overview

8.4.2 Drug Testing Market Revenue and Forecast to 2028 (US$ Mn)

9. APAC Immunohistochemistry Market Analysis– By End User

9.1 Overview

9.2 APAC Immunohistochemistry Market, By End User 2021 & 2028 (%)

9.3 Hospital & Diagnostic Laboratories

9.3.1 Overview

9.3.2 Hospital & Diagnostic Laboratories: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

9.4 Research Institutes

9.4.1 Overview

9.4.2 Research Institutes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

9.5 Others

9.5.1 Overview

9.5.2 Others: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10. APAC Immunohistochemistry Market – Country Analysis

10.1 APAC Immunohistochemistry Market Revenue and Forecasts To 2028

10.1.1 Overview

10.1.2 APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)

10.1.2.1 Japan: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.2.1.1 Japan: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.2.1.2 Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.2.1.2.1 Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.2.1.2.2 Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

10.1.2.1.2.3 Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

10.1.2.1.3 Japan Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

10.1.2.1.3.1 Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

10.1.2.1.4 Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

10.1.2.2 China: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.2.2.1 China: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.2.2.2 China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.2.2.2.1 China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.2.2.2.2 China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

10.1.2.2.2.3 China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

10.1.2.2.3 China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

10.1.2.2.3.1 China: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

10.1.2.2.4 China: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

10.1.2.3 India Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.2.3.1 India: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.2.3.2 India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.2.3.2.1 India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.2.3.2.2 India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

10.1.2.3.2.3 India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

10.1.2.3.3 India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

10.1.2.3.3.1 India: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

10.1.2.3.4 India: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

10.1.2.4 South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.2.4.1 South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.2.4.3 South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.2.4.3.1 South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.2.4.3.2 South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

10.1.2.4.3.3 South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

10.1.2.4.4 South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

10.1.2.5 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.2.5.1 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.2.5.2 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.2.5.2.1 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.2.5.2.2 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

10.1.2.5.2.3 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

10.1.2.5.3 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

10.1.2.5.3.1 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

10.1.2.5.4 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

10.1.2.6 Rest of APAC: Immunohistochemistry Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.6.1 Rest of APAC: Immunohistochemistry Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.6.2 Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.2.6.2.1 Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.2.6.2.2 Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

10.1.2.6.2.3 Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

10.1.2.6.3 Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

10.1.2.6.3.1 Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

10.1.2.6.4 Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

11. Impact Of COVID-19 Pandemic on APAC Immunohistochemistry Market

11.1 APAC: Impact Assessment of COVID-19 Pandemic

12. Industry Landscape

12.1 Overview

12.2 Organic Developments

12.2.1 Overview

12.3 Inorganic developments

12.3.1 Overview

13. Company Profiles

13.1 Cell Signaling Technology, Inc.

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 F. HOFFMANN-LA ROCHE LTD.

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 MERCK KGaA

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 PerkinElmer Inc.

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 THERMO FISHER SCIENTIFIC INC.

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Abcam plc

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Agilent Technologies, Inc.

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 BIO-RAD LABORATORIES INC.

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 Danaher

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 Bio SB

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. APAC Immunohistochemistry Market – Revenue and Forecast to 2028 (USD Million)

Table 2. Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 3. Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 4. Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

Table 5. Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 6. Japan Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

Table 7. Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

Table 8. Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

Table 9. China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 10. China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 11. China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

Table 12. China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 13. China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

Table 14. China: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

Table 15. China: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

Table 16. India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 17. India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 18. India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

Table 19. India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 20. India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

Table 21. India: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

Table 22. India: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

Table 23. South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 24. South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 25. South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

Table 26. South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 27. South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

Table 28. Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 29. Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 30. Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

Table 31. Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 32. Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

Table 33. Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

Table 34. Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

Table 35. Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 36. Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 37. Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

Table 38. Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 39. Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

Table 40. Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

Table 41. Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

Table 42. Organic Developments Done By Companies

Table 43. Inorganic developments done by Companies

Table 44. Glossary of Terms

LIST OF FIGURES

Figure 1. APAC Immunohistochemistry Market Segmentation

Figure 2. APAC Immunohistochemistry Market Segmentation, By Country

Figure 3. APAC Immunohistochemistry Market Overview

Figure 4. Antibodies Segment Held the Largest Share of the Market in 2021

Figure 5. India to Show Significant Growth During Forecast Period

Figure 6. APAC PEST Analysis

Figure 7. Impact Analysis of Drivers and Restraints Pertaining to APAC Immunohistochemistry Market

Figure 8. APAC Immunohistochemistry Market – Revenue Forecast and Analysis

Figure 9. APAC Immunohistochemistry Market, by Product 2021 & 2028 (%)

Figure 10. APAC Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 11. APAC Primary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 12. APAC Secondary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 13. APAC Equipment: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 14. APAC Slide Staining Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 15. APAC Tissue Microarrays: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 16. APAC Tissue Processing Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 17. APAC Slide Scanners: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 18. APAC Other Equipments: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 19. APAC Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 20. APAC Histological Stains: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 21. APAC Blocking Sera & Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 22. APAC Chromogenic Substrates: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 23. APAC Stabilizer: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 24. APAC Proteolytic Enzymes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 25. APAC Organic Solvents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 26. APAC Fixation Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 27. APAC Diluents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 28. APAC Kits: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 29. APAC Immunohistochemistry Market Share by Application 2021 & 2028 (%)

Figure 30. APAC Diagnostics Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 31. APAC Cancer Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 32. APAC Infectious Diseases Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 33. APAC Autoimmune Diseases Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 34. APAC Diabetes mellitus Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 35. APAC Nephrological Diseases Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 36. APAC Others Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 37. APAC Drug Testing Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 38. APAC Immunohistochemistry Market, by End User 2021 & 2028 (%)

Figure 39. APAC Hospital & Diagnostic Laboratories: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 40. APAC Research Institutes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 41. APAC Others: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 42. APAC Immunohistochemistry Market Overview, by Country (2021)

Figure 43. APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)

Figure 44. Japan: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 45. China: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 46. India: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 47. South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 48. Australia: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 49. Rest of APAC: Immunohistochemistry Market – Revenue and Forecast to 2028 (USD Million)

Figure 50. Impact of COVID-19 Pandemic in APAC Country Markets

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the APAC immunohistochemistry market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the APAC immunohistochemistry market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth APAC market trends and outlook coupled with the factors driving the immunohistochemistry market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
Asia Pacific Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software an..	May 2022
Asia Pacific Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Elec..	May 2022
Asia Pacific Ground Engaging Tools Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Application (Excavators, Loaders, Bulldozers, an..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000

$3000

GET FREE SAMPLE PDF

Inquire before Buying Inquire for Discount

Subscription Member Price: FREE

Get Subscription

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

Request for Free Sample